News & Events

• October 25, 2023
  

  C-Path Announces Significant Expansion in Neonatal RWD Project

  Details of the expansion will be a highlight of the Institute’s Scientific Breakthrough Summit Oct. 26-27 in D.C. TUCSON, Ariz., October 25, 2023 — Critical Path Institute’s (C-Path) International Neonatal Consortium (INC) and the Institute for Advanced Clinical Trials for Children (I-ACT) are thrilled to announce a significant expansion of neonatal data in their Real-World...
• August 17, 2023
  

  C-Path to Host a Scientific Breakthrough Summit Oct. 26-27

  Addressing Unmet Regulatory Needs and Drug Development Opportunities through Collaborations in Type 1 Diabetes, Alpha-1 Antitrypsin Deficiency, Lysosomal Disorders, and Vulnerable Populations including Neonates TUCSON, Ariz., Aug. 17, 2023 – Critical Path Institute (C-Path), a leading nonprofit dedicated to accelerating drug development to advance better treatments for people worldwide, is pleased to announce its upcoming...
• July 18, 2023
  

  C-Path Integrates European Offices to Optimize Global Operations and Collaborative Partnerships

  C-Path ts activity in Europe and broaden its global operations. C-Path operates in Europe as a nonprofit organisation that builds consensus among its stakeholders from around the world to improve public health. The organisation shares expertise, data, risks and costs to move regulatory science forward.

• June 8, 2023
  

  C-Path and I-ACT Collaborate on EHR Data Transfer

  Critical Path Institute’s (C-Path) International Neonatal Consortium (INC) and the Institute for Advanced Clinical Trials for Children (I-ACT) have announced a collaboration to integrate patient-level data from Electronic Health Records (EHR) as part of a real-world data (RWD) project. This project aims to generate actionable real-world evidence (RWE) for pediatric drug development, marking this data transfer a significant milestone for both C-Path and I-ACT.

• June 6, 2023
  

  Shaping the Global Innovation and Access Landscape for Better Paediatric Medicines: C-Path Becomes Official Partner of WHO

  Critical Path Institute (C-Path), a leading global nonprofit committed to expediting drug development through the acceleration of regulatory-endorsed solutions, today announced an official partnership with the World Health Organization’s (WHO) Global Accelerator for Paediatric Formulations (GAP-f) project.